ACAD
Acadia Pharma (ACAD)
NASDAQ
$18.52+$0.15 (+0.81%)
Price as of Nov 12, 2026 8:30 AM EST
  • $3.2B
    Market Cap
  • -23.87%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 84
Valuation
ACAD
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 21
Valuation
ACAD
vs History
vs S&P 500
3-Month Momentum
-36.69%
12-Month Momentum
-21.50%
3-Month Risk Adjusted Momentum
-198.15%
12-Month Risk Adjusted Momentum
-58.83%

True Yield

N/A
Valuation
ACAD
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 62
Valuation
ACAD
vs History
vs S&P 500
Ohlson's O-Score
10